Gefapixant for treating refractory or unexplained chronic cough (terminated appraisal) (TA969)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 30 April 2024
Nitazoxanide for treating the common cold in people 12 years and over TS ID 10548Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC